Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
EEarth Corporation logo
4985TSE Prime

Earth Corporation

アース製薬 Yahoo Finance

Recent & upcoming events

Aug 6
Earnings 2:00
Q2 earnings announcement (scheduled)
Add to Google Calendar
May 13
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Mar 24
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
Feb 13
Earnings 1:00
FY earnings announcement (scheduled)
Add to Google Calendar
Nov 9
Earnings 1:00 approx.
Q3 earnings announcement (scheduled)
Add to Google Calendar
Dec 27
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Dec 28
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
2027
Feb 8
Est.
Earnings 1:00 approx.
Full-year earnings
Add to Google Calendar
May 3
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar
Jun 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Jun 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Aug 2
Est.
Earnings 2:00 approx.
Q2 earnings
Add to Google Calendar
Nov 1
Est.
Earnings 2:00 approx.
Q3 earnings
Add to Google Calendar

KPI highlights

FY25
Revenue ¥179.18B YoY +5.9%
Operating income ¥8.09B margin 4.5%
Net income ¥5.24B YoY +50.7%
EPS ¥240 YoY +51.6%
P/E —
ROE 7.3% Equity ratio 50% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2026/12 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥188.00B +4.9%
Operating income ¥9.00B +11.3%
Net income ¥6.20B +18.4%
EPS ¥284 +18.2%

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q3FY23 Q4FY24 Q1FY24 Q2FY25 Q1FY26 Q1
Revenue —¥31.57B————
Operating income —¥-2.85B————
Net income —¥-2.34B————
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2020–2025）

事業法人 24.6%国内機関 12.3%個人 4.9%未開示 57.2%202020212022202320242025
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

大塚製薬株式会社 10.1%大塚製薬株式会社株式会社大塚製薬工場 8.9%株式会社大塚製薬工場日本マスタートラスト信託銀行株式会社 8.7%日本マスタートラスト信託銀行株式会社（信託口）アース製薬社員持株会 4.9%アース製薬社員持株会大鵬薬品工業株式会社 2.7%大鵬薬品工業株式会社株式会社日本カストディ銀行（信託口） 2.1%株式会社日本カストディ銀行（信託口）大塚化学株式会社 1.8%大塚化学株式会社株式会社中国銀行 1.6%株式会社中国銀行大塚エステート株式会社 1.1%大塚エステート株式会社202020212022202320242025

Top shareholders — actual figures (as of 2025)

Holder Shares held Ratio Source
大塚製薬株式会社 2,200,000 10.1% Yuho (EDINET)
株式会社大塚製薬工場 1,948,000 8.9% Yuho (EDINET)
日本マスタートラスト信託銀行株式会社（信託口） 1,898,000 8.7% Yuho (EDINET)
アース製薬社員持株会 1,062,000 4.9% Yuho (EDINET)
大鵬薬品工業株式会社 600,000 2.7% Yuho (EDINET)
株式会社日本カストディ銀行（信託口） 450,000 2.1% Yuho (EDINET)
大塚化学株式会社 400,000 1.8% Yuho (EDINET)
株式会社中国銀行 340,000 1.6% Yuho (EDINET)
大塚エステート株式会社 239,000 1.1% Yuho (EDINET)
JP MORGAN CHASE BANK 385781 213,000 1.0% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

7/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 3.5%
✓ Positive operating cash flow ¥10.79B
✓ ROA improved YoY 2.6% → 3.5%
✓ Operating CF exceeds net income (accrual quality) OCF ¥10.79B / net income ¥5.24B
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 50.8% → 50.2%
✓ Current ratio improved 1.30× → 1.34×
✓ No dilution (shares outstanding did not increase) 22,209,000 → 22,209,000
✓ Gross margin improved 40.7% → 41.7%
✗ Asset turnover improved 1.25× → 1.20×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio 50.2%
Current ratio 1.3×
Years of positive operating CF 10 of last 10 yrs
Payout ratio 70%
Latest fiscal year result Profit (net income ¥5.24B)

Performance history

Last 10 years
0億円509億円1,019億円1,528億円2,038億円 FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

Income & assets

Unit: ¥100M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue 1,6851,7971,8111,8951,9602,0381,5231,5831,6931,792
Operating income 55.544.610.439.211410774.363.764.380.9
Ordinary income 59.949.913.843.311711481.367.973.688.9
Net income 33.622.1-1.4212.535.571.453.041.034.852.4
Total assets 1,0741,1821,0931,0741,1991,2071,2451,3241,3561,494
Equity 492505444443598646680720747813

Indicators & cash flow

Unit: ¥100M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
EPS ¥167¥109¥-7¥62¥171¥324¥240¥186¥158¥240
ROE 7.7%5.0%-0.3%3.1%7.4%12.4%8.6%6.3%5.1%7.3%
Operating CF 80.991.83.6910024648.139.075.2140108
Investing CF -55.0-140-15.2-39.9-31.7-32.2-62.7-101-52.8-37.6
Financing CF -22.232.6-32.0-47.7-49.4-46.1-44.648.9-99.0-10.2
FCF 25.9-48.2-11.560.321415.9-23.7-26.186.870.4

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓ Dividend grower ✓

Sector positioning

Relative standing within the sector

IR disclosure history

Timely disclosures & annual reports
Is this information incorrect?

Data provided by Twelve Data